Introduction
Bone formation is a complex process that requires bone growth and remodeling. The extracellular matrix of hard tissues is largely comprised of type I collagen and noncollagenous proteins (NCPs). 1, 2 Some of the predominant NCPs of the bone matrix that play a functional role in osteoblast differentiation and matrix mineralization are dentin matrix protein 1 (DMP1), osteopontin, osteonectin, matrix Gla protein, bone sialoprotein, and osteocalcin. Several of these NCPs exert a temporal and spatial influence on oriented hydroxyapatite growth. Among the NCPs, there exists a seminal matrix protein termed DMP1, which was first cloned from a rat cDNA library. 3 Though the nomenclature implies a function in the dentin matrix, the molecule has also been isolated in osseous tissue and has thus been hypothesized to also have a function in the development and ossification of bone. 4, 5 Following the cloning of rat DMP1, several studies have been undertaken with the goal of characterizing the molecule and determining its function in the biology of calcified tissues. [6] [7] [8] Defining the process of hard tissue formation is central to understanding the process of osteogenesis and subsequently, related pathological entities.
DMP1 is a 58 kDa phosphoprotein with a pI of 3 found in bone and dentin matrix. 3 In the bone, DMP1 expression is evident throughout the process of ossification. 9, 10 Orthopedic Research and Reviews downloaded from https://www.dovepress.com/ by 54.70.40.11 on 07- Dec-2018 For personal use only. Powered 
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The first evidence for a functional role for DMP1 in mineralization, resulted from in vitro studies, wherein DMP1 was shown to nucleate hydroxyapatite. 7, 11 However, DMP1-null mice showed no apparent skeletal or tooth phenotype during early development, suggesting functional redundancy due to overlapping expression with other noncollagenous proteins like BAG-75. Feng and colleagues have demonstrated that DMP1-null mice have defective osteocyte maturation, leading to pathological changes in bone mineralization and defects in cartilage formation. [12] [13] [14] In the present study, we examined the biological function of DMP1 in vivo by generating a transgenic (TG) mouse overexpressing DMP1. A cytomegalovirus (CMV) promoter was used as it is reputed to be one of the strongest and contains most promiscuous regulatory elements for directing high transgene expression. 15, 16 In this study, we sought to characterize the skeletal phenotype of the TG mice overexpressing DMP1.
Materials and methods

DnA constructs
The CMV-DMP1 plasmid was generated by first polymerase chain reaction (PCR) amplifying the rat DMP1 cDNA with the coding region and 3´ untranslated region. This fragment was then cloned into KpnI and XhoI sites of the pcDNA 3.1+ vector (Invitrogen, Carlsbad, CA, USA) and digested with Bgl II and Pvu II to release the cassette containing the CMV-DMP1 and bovine growth hormone poly A transgene. The released DNA fragment (transgene) was microinjected into mouse blastocysts.
generation and genotyping of Tg mice
Microinjections into CD-1 (Charles River Laboratories, Wilmington, MA, USA) outbred mice were performed at the University of Illinois at Chicago Transgenic Facility under institutionally approved protocols. The F 0 DMP1-positive lines were identified by isolating genomic DNA from tail fragments using DNeasy tissue kit (Qiagen, Valenica, CA, USA). PCR was carried out with CMV-specific primers. Briefly, 100 ng of genomic DNA was used in the PCR reaction with 35 cycles of 94 °C for 30 sec, 56 °C for 30 sec, and 72 °C for 30 sec. Genotyping was carried using the following specific primers for CMV promoter.
CMV Forward 5´---GTTCATAGCCCATATATG-GAGTTCCGCG ---3Ć
MV Reverse 5´ -----GACCTCCCACCGTACAC-GCCTAC -----3´.
Southern blot analysis was also performed to confirm the presence of DMP1 transgene.
Western blot analysis
Total protein from liver, muscle, and heart tissue samples were extracted with T-PER lysis buffer (Pierce Biotechnology, Rockford, IL, USA). Briefly, 0.1 g of fresh tissue from new born animals were homogenized in 2 ml of T-PER lysis buffer and centrifuged at 15,000 × g for 15 min and the supernatant collected. Western blot analysis was performed with affinity-purified DMP1 antibody. Total protein from the bone tissue was isolated by homogenizing the femurs from three-day-old animals in the presence of liquid nitrogen and extracted with 0.5 M EDTA (ethylenediaminetetraacetic acid) at pH 7.5 in the presence of a protease inhibitor mixture.
histological analysis
The hind limb and the mandibles were dissected out from the TGs (n = 5) and the wild type (WT; n = 5) at four weeks of age. The tissues were decalcified and embedded in paraffin. Sections were cut at 5 µm thickness and treated with various histological stains. Hematoxylin and eosin (H&E) stain was used for outlining the general tissue architecture, Masson's trichrome was used to detect the presence of connective tissue fibers and Safrannin O/Fast green was used to detect proteoglycans.
skeleton preparation and analysis
Skeletons were prepared as described by Tylzanowski and colleagues. 17 Briefly, mice at three days, five days, and two weeks postnatal were sacrificed with carbon dioxide (n = 5). The nonskeletal tissues were digested with 2% potassium hydroxide and then fixed in 95% ethanol for 72 hours, fixed in acetone for 24 hours and stained with alcian blue for 36 hours. The stained bodies were then washed in 95% ethanol and placed in a 95% ethanol bath for 48 hours, changing the solution after 24 hours. Photographs of the caudal vertebral column were taken prior to clearing and counterstaining using a 5 megapixel Fuji digital camera (Fujifilm, Valhalla, NY, USA). The bodies were then placed in a 1% potassium hydroxide solution until clearing was evident, followed by alizarin red counterstaining for 24 hours. Secondary clearing was performed with 1% potassium hydroxide for a minimum of 48 hours, after which the specimens were treated with a series of 2% potassium hydroxide-glycerol solutions every 12 hours in the KOH-glycerol ratios of 80:20, 60:40, 40:60, and 20:80. Final storage was in 100% glycerol. Images of cleared specimens were recorded with a 5 megapixel Fuji digital camera on a Kaiser light box. Cartilaginous tissues 
Radiographic analysis
Phenotypic changes were also monitored by a noninvasive, high-magnification X-ray analysis to characterize the bones of the craniofacial region of TG and WT four-week-old animals (n = 5) via high-resolution digital radiography using a Faxitron model MX-20 digital radiography machine (Faxitron Corporation, Lincolnshire, IL, USA). Specimens subject to comparison were exposed concurrently on the digital sensor and the radiographic densities of the craniofacial region compared between the WT and the TG animals.
Bone formation rate
Bone formation rate was quantified using flurochrome injections at two different time points in male mice (TG, n = 7; WT, n = 8). At day 14, the mass of each mouse was determined and 0.09 mg xylenol orange per gram of mouse tissue was administered. At day 24, the mice were injected with a solution of 0.01 mg tetracycline per gram of mouse tissue. At day 28, the mice were sacrificed and the femurs removed. The femurs were rinsed with phosphate-buffered saline (PBS), fixed overnight in alcohol formalin and dehydrated with successive baths of 70%, 80%, 96%, and 100% ethanol at 4 °C. Following dehydration, the bones were mounted in epoxide resin. Ground sections of femurs (cross-sectional) at the proximal diaphysis were prepared to approximately 150 micron thickness. Ground sections were then photographed under a Zeiss Observer D.1 flourescence microscope/AxioCam MRc digital camera (Carl Zeiss, Maple Grove, MN, USA) utilizing GFP (green) and Cy 3 (red) wavelength filter cubes at 5x magnification. The Axiovision (v 4.6.3.0) imaging software was used to trace the xylenol orange flurochrome band and exterior cortical plate of the tetracycline-stained portion of each section. The area (in square micrometers) between the two bands was calculated via the integrated software algorithms and the mean bone formation rate along with the standard deviation was calculated to three significant figures for both WT and TG mice.
immunohistochemical analysis
Immunohistochemical analysis was performed on serial sections with Col X antibody (kind gift from Dr Horton). The paraffin sections were deparaffinized in xylene, rehydrated, and rinsed three times (5 min each) in PBS (pH 7.4) prior to quenching of endogenous peroxidase activity (3% H 2 O 2 in PBS at room temperature for 10 min). The sections were then rinsed three times (5 min each) in PBS and then blocked with 10% normal goat serum for 45 min at room temperature. The sections were again rinsed in PBS solution and incubated with primary antibodies against type X Col at 1:250 dilution (overnight at 4 °C). A negative control was included by using an equal concentration of rabbit pre-immune serum as primary antibody. Following incubation with the primary antibody, the tissue sections were rinsed three times (15 min each) in PBS and then incubated with an alkaline phosphatase conjugated goat anti-rabbit immunoglobulin (1:500) for 60 min at room temperature. Stained sections were digitally archived using a Leica DMLB light microscope (Leica Microsystems, Wetzlar, Germany) and MagnaFire software (Optronics, Goleta, CA, USA).
stimulation of rat bone marrow stem cells with DMP1
Rat bone marrow stem cells (RBMSCs) were obtained from Tulane Cancer centre. These cells were cultured in alpha minimal essential medium (MEM) supplemented with l-glutamine, 5% fetal bovine serum (FBS) and 1% penicillin-streptomycin. The cells were seeded in 6-well plates and grown to 70% confluency. Media was changed every two days. The cells were cultured in complete medium supplemented with 0.5% FBS 12-16 hours before the start of the experiment. The cells were treated with 0 (control), 250 or 500 ng/ml of recombinant DMP1 for varying time points (two and five days). Total RNA was isolated after DMP1 treatment using TriZol (GIBCO, Carlsbad, CA, USA). 3 µg of DNaseI treated total RNA was reverse transcribed using Superscript III (GIBCO) for 90 min at 50 °C. PCR reaction was carried out using primers for Cbfa1, BMP2, OCN, and COL1. PCR products were amplified for 35 cycles (30 sec at 94 °C, 30 sec at 56 °C, and 30 sec at 72 °C) in a DNA thermal cycler (Eppendorf, Westbury, NY, USA). The DNA products were resolved on agarose gels and visualized with ethidium bromide staining. The intensity of the PCR products was quantitated using National Institutes of Health software. The expression level was normalized with GAPDH (glyceraldehyde 3-phosphate dehydrogenase). Gene-specific primers were designed from the DNA sequences at the National Centre for Biotechnology Information gene databank.
statistical analysis
Data are expressed as the mean ± standard deviation of at least three independent experiments or five animals per group, respectively. Statistical analysis was performed 
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by one-way analysis of variance, followed by Student's unpaired t-test. P values less than 0.05 were considered significant.
Results
generation of a Tg mouse overexpressing DMP1
Three TG mouse lines with different integration of the transgene were generated. Two of these lines expressed high levels of the transgene based on the PCR results (data not shown). Because the two TG lines showed no phenotypic differences, line 129 was used for further analysis. PCR results ( Figure 1 ) demonstrated a fivefold increase in the transgene expression in the liver and a twofold increase in bone and teeth when compared with the WT. Western blotting analysis further confirmed high levels of expression of DMP1 in soft and mineralized tissues ( Figure 1C ). These results confirmed that in the TG mouse line, DMP1 expression is under the control of the CMV promoter.
Tg mice exhibit abnormalities in the skeletal phenotype Body weight comparison between the TG and WT mice demonstrate higher body mass with age in the TG mice, indicating phenotypic changes during growth and development (data not shown). Consequences of DMP1 overexpression on skeletal abnormalities were determined by staining whole skeletal preparations with alcian blue and alizarin red. Skeletal staining of the three-day-old mice revealed accelerated mineralization of the intramembranous bones. In the craniofacial area, enhanced mineralization around the suture was present in the TG line when compared with the WT line (Figure 2A ). In the TG, the peripheral borders of the flat bones of the cranium displayed a sharp, irregular appearance, which suggests more aggressive mineralization when compared with the WT (Figure 2A) .
High-resolution digital radiography of four-week-old TG mice revealed increased radiodensity in the craniofacial region in comparison to the WT mice ( Figure 2B ). Specifically, increased radiodensity was noted in the occipital area of the skull and the palatal area. In addition to this, instances of increased radiodensity were noted in the bony labyrinth of the temporal bone as well as the nasal conchae ( Figure 2B ). This was verified by performing concurrent imaging of the specimens on the digital sensor. This data suggests that DMP1 regulates the osteoblastic activity responsible for intramembranous bone formation.
Skeletal staining of the five-day-old mice revealed differences between the TG and WT in the ossification of the carpal bones ( Figure 3A, arrows) . By day 5, the WT demonstrated initial mineralization of only the trapezoid, pisiform and/or triquetral bones. In contrast, the TG line displayed ossification of these bones as well as the capitate, hamate, falciform carpal, and scaphoid. In addition, ossification centers in the distal epiphyseal plate of the 5th metacarpal have appeared in the TG line by day 5, but have not developed yet in the WT. Thus, increased ossification of the carpal bones were observed. Calcification of the caudal portion of the axial skeleton also showed increased ossification in the TG line ( Figures 3B and C) . TG mice had an average of four additional tail vertebrae that had begun Figure 3B ). Upon clearing with potassium hydroxide, the proteoglycan deficiency in the TG mice remained evident, both in the two-and the four-week-old mice ( Figure 3C) . Overall, increased alizarin red staining in the skeleton of the TG mice demonstrates enhanced mineralization.
Tg mice exhibit abnormalities in the growth plate
Histological H&E staining of the skeleton revealed a narrower cartilaginous growth plate in the epiphysis of the TG mice at four weeks of age ( Figure 4A ). In addition to this, differences were noted in the cellular arrangement and morphology of the cartilaginous growth plate associated with the head of the femur ( Figure 4A ). The TG mouse displayed altered cell morphology and architecture, specifically lacking the classical columnar arrangement noted in the zone of proliferation and maturation stage and instead displayed a prevalence of hypertrophic, calcifying cartilage cells. Presence of hypertrophic chondrocytes was confirmed by the presence of type X collagen antibody ( Figure 4C) . Moreover, the bone around the articular surface was highly mineralized ( Figure 4B) . Saffrannin O staining clearly demonstrated that the bone volume in the primary spongiosa just beneath the growth plate of the tibiae was significantly 
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increased resulting from the early differentiation of the chondrocytes ( Figure 4B ). These data suggest that the early hypertrophic phenotype of the chondrocytes is due to the overexpression of DMP1 in these cells.
Assessment of bone formation rate
Analysis of the mean area of the bone formed (in square micrometers) between serial xylenol orange and tetracycline injections ( Figures 5A and B) in the femurs revealed that the phenotype seen in the TG mice is caused by an increase in bone formation rate. Over the 14-day study interval, the TG mice displayed an average of 521,000 µm 2 (standard error [SE] ± 58,100 µm 2 ) of increased bone area, while the WT animals exhibited an average of 468,000 µm 2 (SE ± 84,600 µm 2 ) of increased bone area ( Figure 5C ). Thus the TG animals exhibited an average of 11.3% increase in the bone formation rate over the WT animals up to four weeks of age.
Terminal differentiation of RBMscs to osteoblasts in the presence of DMP1
To define the molecular mechanism for the accelerated osteoblast differentiation that was observed in the TGs, rat bone marrow stem cells were treated with recombinant DMP1 for specified time periods. Reverse-transcriptase-PCR (RT-PCR) analysis ( Figure 6 ) showed an upregulation of lineage specific early markers such as Cbfa1, signaling molecules like BMP2, and late markers for mature osteoblasts such as type I collagen and osteocalcin. As shown in Figure 6A , BMP2, Cbfa1, type I collagen, and OCN expression levels increased within two days and osteocalcin and BMP2 collagen expression increased several folds within five days ( Figure 6B ). This osteoblast lineage specific expression was further confirmed by accelerated mineralized nodule formation in RBMSCs treated with DMP1 ( Figures 6C and D) . Taken together, these results indicate that DMP1 influences the differentiation of bone marrow stem cells into functional osteoblasts.
Discussion
DMP1 is a biologically-active molecule and has been implicated to have a regulatory function during early osteoblast and odontoblast differentiation as well as during the formation of the calcified extracellular matrix, by various means, including the development of a DMP1-null mouse. 14, [18] [19] [20] [21] [22] [23] Inactivation of the DMP1 gene did not induce gross morphological abnormalities in bone and dentin during early development, partly because DMP1 has to the growth plate (gP). in the WT, the bone appears less contiguous, and larger marrow cavity is observed. note the thickness of the cortical bone in Tg mice when compared with the WT mice as indicated by the arrows in the cortical bone area. C) Representative micrographs of the tibial section of WT and Tg mice stained immunohistochemically for type X collagen. note increased expression of col X in the hypertrophic chondrocytes of the TG mice (Magnification, x400).
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C several homologies to other proteins. 24 The first 10 amino acid residues are identical to the N-terminal sequence of bone glycoprotein BAG-75 (bone acidic glycoprotein -75) and to the first eight residues of the core protein of a bone 
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proteoglycan designated as HS-PGIII. 25 Moreover, DMP1 belongs to a class of small, integrin binding proteins which is currently represented by the glycophosphoproteins encoded by 5 genes clustered within a 372 kb region of human chromosome 4 called the SIBLING (small integrin-binding ligand, N-linked glycoprotein) family. 26 Therefore, the phenotype in DMP1 knockout mice might be due to unexpected compensatory or functional redundancy mechanisms that might be activated when a gene is ablated. In this study, a gain-of-function approach was employed to define the in vivo function of DMP1, by generating a DMP1-overexpressing TG mouse using a CMV promoter. As anticipated, the TG mice exhibited accelerated mineralization in osseous tissues.
On a microscopic level, examination of the mouse femurs revealed alterations in the morphology of the bony tissues. Specifically, the growth plate of the DMP1-overexpressing mice was found to be narrower and displayed altered chondrocyte morphology and architecture. In addition, the growth plate lacked the classical well-defined columnar arrangement of the chondrocytes that progress through proliferative, prehypertrophic and terminally differentiating hypertrophic stages. Instead, the epiphyseal growth plate displayed an accumulation of disorganized hypertrophic chondrocytes. This indicates that DMP1 overexpression was responsible for accelerated chondrocyte hypertrophy that resulted in depositing a cartilaginous matrix. The matrix provided the template for differentiating osteoblasts from the bone marrow to form trabecular bone at the site of the bone collar. We have demonstrated earlier that DMP1 upregulated the expression of Cbfa1 in mouse calvarial MC3T3-E1 cells. 27 Thus enhanced expression of Cbfa1 in the growth plate chondrocytes might accelerate chondrocyte hypertrophy. This is in agreement with the results that overexpression of Cbfa1 accelerated chondrocyte maturation and endochondral ossification while Cbfa1 deficient mice show limited cartilage calcification. [28] [29] [30] [31] On the other hand, DMP1 null mice exhibited a severe defect during postnatal chondrogenesis and presented a chondroplasia-like phenotype. 13 Taken together, these data indicate that DMP1 can enhance chondrocyte hypertrophy and this may be associated with upregulation of Cbfa1.
Skeletal staining revealed a similar pattern of decreased cartilaginous tissue formation at the macroscopic level in the DMP1 TG mice. Reduced alcian blue staining of the intervertebral discs of the TG mice clearly demonstrates that the cartilage forming mechanisms were altered, facilitating rapid mineralization. This was further confirmed after counterstaining with alizarin red. In three-day-old TG lines, evidence for enhanced mineralization was further provided by the aggressive suture closure in the TG line and mineralization of the caudal vertebrae. By day 5, developing TG mice displayed aggressive mineralization of the carpal and metacarpal bones, which provide evidence that overall mineralization, increased rapidly at the active ossification centers during early skeletal development. This increased osteoblast differentiation was reflected in the extensive mineralization at the bone collar in the TGs. Consistent with the observed histological and staining data, high resolution digital radiography revealed increased radiodensity of the craniofacial bones in the TG mice. Dynamic histomorphometric analysis revealed that the cortical bone area formed over a 14-day period in the TG mice was greater than the WT mice. On average, TG mice displayed a 11.1% increase in bone formation over the control animals. In contrast, the DMP1 knockout mice exhibited decreased endochondral ossification and the mice had defective osteocyte maturation leading to rickets and osteomalacia. 14, 15 Thus, the presence of DMP1 in TG mice consistently developed a propensity for accelerated bone formation during early development.
Our analysis with the bone marrow stem cells further demonstrate that the mineralized phenotype could be due to the commitment and accelerated differentiation of these cells to the osteoblast lineage. Thus, the enhanced mineralization phenotype of the femurs at four weeks is consistent with DMP1 as a positive regulator of mineralized matrix formation. This finding corroborates well with our earlier published data that overexpression of DMP1 accelerates maturation of preosteoblasts to fully differentiated osteoblasts accompanied by upregulation of target genes that accelerate osteoblast differentiation. Similar results were obtained when ectopic expression of the transcription factor Fra-1 in TG mice led to increased bone mass by regulating bone matrix production by osteoblasts and chondrocytes. 32 In conclusion, our data suggests that robust mineralization observed in the DMP1 overexpressing TG mice could be correlated with the active synthesis of transcription factors, Figure Role of DMP1 in osteoblastogenesis. Rat bone marrow stem cells (RBMscs) were treated with either 250 or 500 ng of DMP1 for two A) or five days B). Total RnA was extracted and the expression of cbfa1, BMP2, Ocn, and col1 (primer sequences were obtained from genBank) were detected by semi-quantitative reverse-transcriptasepolymerase chain reaction. note expression levels of "early" and "late" markers increased with the commitment and differentiation of RBMscs to the osteogenic lineage. Mineralized nodule assay was performed by treating RBMscs with 500 ng DMP1 for 30 days. von Kossa staining shows the presence of mineralized nodules only in RBMscs treated with DMP1 D) and not in untreated cells C). Abbreviation: DMP1, dentin matrix protein 1. 
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